ClearPoint Neuro (CLPT) Net Cash Flow (2011 - 2026)

ClearPoint Neuro (CLPT) has 15 years of Net Cash Flow data on file, last reported at -$10.5 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 35.51% year-over-year to -$10.5 million; the trailing twelve-month figure through Mar 2026 stood at $24.2 million (up 205.17% YoY), and the FY2025 full-year result was $26.9 million, up 985.84% from the prior year.
• Net Cash Flow eased to -$10.5 million in Q1 2026, from $8.6 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $29.4 million in Q2 2025 to a low of -$26.1 million in Q2 2022.
• A 5-year average of -$1.0 million and a median of -$2.5 million in 2024 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow sank 683.86% in 2022 and soared 1270.57% in 2025, its largest moves.
• Tracing CLPT's Net Cash Flow over 5 years: stood at $8.9 million in 2022, then tumbled by 113.5% to -$1.2 million in 2023, then declined by 22.21% to -$1.5 million in 2024, then surged by 682.16% to $8.6 million in 2025, then sank by 222.28% to -$10.5 million in 2026.
• Business Quant data shows CLPT's Net Cash Flow at -$10.5 million in Q1 2026, $8.6 million in Q4 2025, and -$3.3 million in Q3 2025.